Published in Am J Clin Pathol on February 01, 1978
The use of cyclosporin A and prednisone in cadaver kidney transplantation. Surg Gynecol Obstet (1980) 7.40
Liver transplantation (1). N Engl J Med (1989) 4.53
Gamma ray-induced loss of expression of HLA and glyoxalase I alleles in lymphoblastoid cells. Proc Natl Acad Sci U S A (1980) 4.35
Cyclosporin A and steroid therapy in sixty-six cadaver kidney recipients. Surg Gynecol Obstet (1981) 2.92
Successful liver transplantation from crossmatch-positive donors. Transplant Proc (1981) 2.80
Thoracic duct drainage before and after cadaveric kidney transplantation. Surg Gynecol Obstet (1979) 2.33
Hamster-to-rat heart and liver xenotransplantation with FK506 plus antiproliferative drugs. Transplantation (1993) 2.17
Hepatitis B virus (HBV)-specific cytotoxic T-cell response in humans: production of target cells by stable expression of HBV-encoded proteins in immortalized human B-cell lines. J Virol (1992) 1.94
Factors affecting posttransfusion platelet increments, platelet refractoriness, and platelet transfusion intervals in thrombocytopenic patients. Blood (2005) 1.94
Surgical techniques and innovations in living related liver transplantation. Ann Surg (1993) 1.88
Evidence for hyperacute rejection of human liver grafts: The case of the canary kidneys. Clin Transplant (1989) 1.74
Cytotoxic T cells specific for glutamic acid decarboxylase in autoimmune diabetes. J Exp Med (1995) 1.67
Thoracic duct fistula and renal transplantation. Ann Surg (1979) 1.60
Humoral response to wheat protein in patients with coeliac disease and enteropathy associated T cell lymphoma. Br Med J (Clin Res Ed) (1986) 1.59
In vitro proliferative responses and antibody titers specific to human acetylcholine receptor synthetic peptides in patients with myasthenia gravis and relation to HLA class II genes. J Clin Invest (1988) 1.57
Antikeratin antibodies in serum and synovial fluid show specificity for rheumatoid arthritis in a study of connective tissue diseases. Ann Rheum Dis (1985) 1.54
HLA-D region genes and rheumatoid arthritis (RA): importance of DR and DQ genes in conferring susceptibility to RA. Ann Rheum Dis (1992) 1.52
Hamster to rat kidney xenotransplantation. Effects of FK 506, cyclophosphamide, organ perfusion, and complement inhibition. Transplantation (1995) 1.45
Deliberate donor-specific blood transfusions prior to living related renal transplantation. A new approach. Ann Surg (1980) 1.45
Anti-DNA autoantibody-producing hybridomas of normal human lymphoid cell origin. J Clin Invest (1984) 1.40
Differentiation-dependent sensitivity of human B-cell-derived lines to major histocompatibility complex-restricted T-cell cytotoxicity. Proc Natl Acad Sci U S A (1986) 1.38
DR and non-DR Ia allotypes are associated with susceptibility to coeliac disease. Gut (1985) 1.35
Individuals with IgA deficiency and common variable immunodeficiency share polymorphisms of major histocompatibility complex class III genes. Proc Natl Acad Sci U S A (1989) 1.29
Gene conversion in steroid 21-hydroxylase genes. Am J Hum Genet (1990) 1.28
Volumetric and functional heterogeneity of human monocytes. J Clin Invest (1980) 1.19
Preformed lymphocytotoxic antibodies: the effects of class, titer and specificity on liver vs. heart allografts. Hepatology (1992) 1.18
Gluten specific suppressor T cell dysfunction in coeliac disease. Gut (1986) 1.17
HLA polymorphism in the Havasupai: evidence for balancing selection. Am J Hum Genet (1993) 1.12
Detection of disease-specific restriction fragment length polymorphisms in pemphigus vulgaris linked to the DQw1 and DQw3 alleles of the HLA-D region. Proc Natl Acad Sci U S A (1987) 1.11
Gene conversion-like events cause steroid 21-hydroxylase deficiency in congenital adrenal hyperplasia. Proc Natl Acad Sci U S A (1987) 1.11
The HLA-DR and DQ genes control the autoimmune response to DNA topoisomerase I in systemic sclerosis (scleroderma). J Clin Invest (1993) 1.10
Histocompatibility antigens in a population based silicosis series. Br J Ind Med (1989) 1.09
Immunologically silent cancer clone transmission from mother to offspring. Proc Natl Acad Sci U S A (2009) 1.07
Association of class II human histocompatibility leukocyte antigens with rheumatic fever. J Clin Invest (1986) 1.06
Familial aggregation of undifferentiated spondyloarthropathy associated with HLA-B7. Ann Rheum Dis (1995) 1.06
Lymphocyte abnormality associated with HLA-B8 in healthy young adults. J Exp Med (1982) 1.05
Liver allograft rejection in sensitized recipients. Observations in a clinically relevant small animal model. Am J Pathol (1993) 1.05
Association of IA-2 autoantibodies with HLA DR4 phenotypes in IDDM. Diabetologia (1996) 1.02
Late follow-up after thoracic duct drainage in cadaveric renal transplantation. Surg Gynecol Obstet (1981) 1.01
Association of HLA-B35 with mucocutaneous lesions in Israeli patients with rheumatoid arthritis receiving gold treatment. Ann Rheum Dis (1988) 1.00
(T,G)-A-L specific immune response potential and HLA typing of Israeli patients with systemic lupus erythematosus. Clin Exp Immunol (1985) 0.99
Hyperacute rejection of a transplanted human heart. Transplantation (1981) 0.98
Genetic distinctions between autoimmune hepatitis in Italy and North America. World J Gastroenterol (2005) 0.95
Profiling of human leukocyte antigens in Eales' disease. Int Ophthalmol (1998) 0.95
Altered gastrointestinal immune response in sarcoidosis. Gut (1988) 0.95
Type 1 diabetes and interferon therapy: a nationwide survey in Japan. Diabetes Care (2011) 0.95
Inverse modulation of IL-10 and IL-12 in the blood of women with preneoplastic lesions of the uterine cervix. Clin Exp Immunol (1998) 0.94
Urticaria/arthritis syndrome: report of four B51 positive patients. Ann Rheum Dis (1989) 0.94
Expression of antigen reactive with a monoclonal antibody to HTLV-1 P19 in salivary glands in Sjögren's syndrome. Clin Exp Immunol (1992) 0.93
Rhodococcus equi-infected macrophages are recognized and killed by CD8+ T lymphocytes in a major histocompatibility complex class I-unrestricted fashion. Infect Immun (2004) 0.92
Immunoregulatory T cell subpopulations in patients with scleroderma using monoclonal antibodies. Clin Exp Immunol (1982) 0.91
Ulcerative colitis and HLA phenotype. Gut (1985) 0.91
Recognition of prostate-specific antigenic peptide determinants by human CD4 and CD8 T cells. Clin Exp Immunol (1998) 0.91
Aetiological role of bacteria associated with reactive arthritis in pauciarticular juvenile chronic arthritis. Ann Rheum Dis (1992) 0.89
Lysis of CD4+ lymphocytes by non-HLA-restricted cytotoxic T lymphocytes from HIV-infected individuals. Clin Exp Immunol (1993) 0.89
The Pharmacogenomic HLA Biomarker Associated to Adverse Abacavir Reactions: Comparative Analysis of Different Genotyping Methods. Curr Genomics (2012) 0.87
Insights into the expression of ABH and Lewis antigens through human bone marrow transplantation. Am J Hum Genet (1981) 0.86
Viral load and clinical disease enhancement associated with a lentivirus cytotoxic T lymphocyte vaccine regimen. Vaccine (2009) 0.86
Human leukocyte antigen distribution in Israeli patients with psoriatic arthritis. Rheumatol Int (2003) 0.86
Regulation of interleukin 2 receptors on T cells from multiple sclerosis patients. Proc Natl Acad Sci U S A (1986) 0.86
HBcAg-specific CD8 T cells play an important role in virus suppression, and acute flare-up is associated with the expansion of activated memory T cells. J Clin Immunol (2003) 0.86
Retrospective tests of B-cold lymphocytotoxins and transplant survival at a single center. Transplant Proc (1979) 0.85
Hepatic cirrhosis in young adults: association with adolescent onset of alcohol and parenteral heroin abuse. Gut (1985) 0.84
Anti-topoisomerase II alpha autoantibodies in systemic sclerosis-association with pulmonary hypertension and HLA-B35. Clin Exp Immunol (2000) 0.84
Polymorphism of major histocompatibility complex extended haplotypes bearing HLA-DR3 in patients with rheumatoid arthritis with gold induced thrombocytopenia or proteinuria. Ann Rheum Dis (1990) 0.84
Evaluation of high functional avidity CTL to Gag epitope clusters in EIAV carrier horses. Virology (2005) 0.83
Failure of low-dose recombinant human IL-2 to support the survival of virus-specific CTL clones infused into severe combined immunodeficient foals: lack of correlation between in vitro activity and in vivo efficacy. Vet Immunol Immunopathol (2007) 0.83
Ankylosing spondylitis in monozygotic twins: studies on immunological parameters. Ann Rheum Dis (1999) 0.83
Hashimoto's thyroiditis and polyarthritis: a possible subset of seronegative polyarthritis. Ann Rheum Dis (1984) 0.83
HLA-A and HLA-B transcription decrease with ageing in peripheral blood leucocytes. Clin Exp Immunol (2001) 0.83
Lymphocyte proliferation responses induced to broadly reactive Th peptides did not protect against equine infectious anemia virus challenge. Clin Diagn Lab Immunol (2005) 0.82
Familial systemic lupus erythematosus: the role of genetic and environmental factors. Ann Rheum Dis (2002) 0.81
Cross-reactive cytotoxic T lymphocytes against human immunodeficiency virus type 1 protease and gamma interferon-inducible protein 30. J Virol (2005) 0.81
Interaction between T cell receptor beta chain and immunoglobulin heavy chain region genes in susceptibility to insulin-dependent diabetes mellitus. Am J Hum Genet (1991) 0.80
Allelic associations and homozygosity at loci from HLA-B to D6S299 in genetic haemochromatosis. J Med Genet (1995) 0.80
HLA-B8 and erythema nodosum. Can Med Assoc J (1982) 0.80
Limb allografts in rats immunosuppressed with cyclosporin A. Ann Surg (1984) 0.80
Effect of FK 506 and antiproliferative agents for heart and liver xenotransplantation from hamster to rat. Transplant Proc (1993) 0.80
Experimental Rhodococcus equi and equine infectious anemia virus DNA vaccination in adult and neonatal horses: effect of IL-12, dose, and route. Vaccine (2007) 0.80
Clinical characteristics of patients with hepatitis C virus-related chronic liver disease seropositive for anticentromere antibody. Dig Dis Sci (2008) 0.79
A novel lymphokine derived from human IgG Fc receptor-bearing B cells: its suppressive effect on activated T and B lymphocytes including tumour cells in vitro. Immunology (1985) 0.79
Preliminary evidence of dual-marked lymphocytes in thoracic duct lymph fluid. Transplant Proc (1980) 0.79
Determinants of effectiveness of thoracic duct drainage for primary cadaver kidney transplantation. Transplant Proc (1981) 0.79
Clinical manifestations of familial 13;18 translocation. J Med Genet (1980) 0.79
A simple, rapid micro-latex fixation test. Clin Exp Immunol (1979) 0.79
Epitope mapping of an HLA-B27 monoclonal antibody that also reacts with a 35-kD bacterial outer-membrane protein. Clin Exp Immunol (1990) 0.79
HLA-A and B antigen frequencies and mesothelioma in relation to asbestos exposure. Br J Cancer (1983) 0.78
A new variant glyoxalase I allele that is readily detectable in stimulated lymphocytes and lymphoblastoid cell lines but not in circulating lymphocytes or erythrocytes. Am J Hum Genet (1981) 0.78
Deficiency of the second complement component association with the HLA haplotype A10, B18 in a normal population. Ann Rheum Dis (1982) 0.78
Analysis of antigen specific T cell helper function in first degree relatives of patients with systemic lupus erythematosus (SLE). Clin Exp Immunol (1986) 0.78
Mechanism of a lymphocyte abnormality associated with HLA-B8/DR3 in clinically healthy individuals. Clin Exp Immunol (1989) 0.77
HLA and insulin-dependent diabetes mellitus in Koreans. Korean J Intern Med (1987) 0.77
Discordant HLA haplotype segregation in a family with progressive extrinsic ophthalmoplegia and ragged red fibres. J Neurol Neurosurg Psychiatry (1983) 0.77
Autoantibodies in chronic arthritis of childhood: relations with each other and with histocompatibility antigens. Ann Rheum Dis (1992) 0.77
Chronic hepatitis C associated with anti-liver/kidney microsome-1 antibody is not a subgroup of autoimmune hepatitis. J Gastroenterol (1997) 0.77
Mechanism of a lymphocyte abnormality associated with HLA-B8/DR3: role of interleukin-1. Clin Exp Immunol (1990) 0.77
Selecting peptides to optimize Th1 responses to an equine lentivirus using HLA-DR binding motifs and defined HIV-1 Th peptides. Immunogenetics (2003) 0.77
Increased PiZ gene frequency for alpha 1 antitrypsin in patients with genetic haemochromatosis. Gut (1995) 0.77
High association of an HL-A antigen, W27, with ankylosing spondylitis. N Engl J Med (1973) 9.90
Serotyping for homotransplantation. 18. Refinement of microdroplet lymphocyte cytotoxicity test. Transplantation (1968) 8.51
Kidney transplantation under FK 506. JAMA (1990) 7.45
The use of cyclosporin A and prednisone in cadaver kidney transplantation. Surg Gynecol Obstet (1980) 7.40
Significance of the positive crossmatch test in kidney transplantation. N Engl J Med (1969) 5.50
Autologous stimulation of human lymphocyte subpopulation. J Exp Med (1975) 4.80
Cytotoxins in disease. Autocytotoxins in lupus. N Engl J Med (1970) 4.40
Serotyping for homotransplantation. X. Survival of 196 grafted kidneys subsequent to typing. Transplantation (1967) 4.16
Shwartzman reaction after human renal homotransplantation. N Engl J Med (1968) 4.05
Adeno-associated virus vectors can be efficiently produced without helper virus. Gene Ther (1998) 3.77
Kidney preservation for transportation. Initial perfusion and 30 hours' ice storage. Lancet (1969) 3.67
Effect of blood transfusions on subsequent kidney transplants. Transplant Proc (1973) 3.42
Chimerism after liver transplantation for type IV glycogen storage disease and type 1 Gaucher's disease. N Engl J Med (1993) 3.36
Kidney transplantation under FK 506 immunosuppression. Transplant Proc (1991) 3.31
Nomenclature for factors of the HLA system, 2010. Tissue Antigens (2010) 3.22
Effect of pravastatin on outcomes after cardiac transplantation. N Engl J Med (1995) 3.11
Chronic survival after human renal homotransplantation. Lymphocyte-antigen matching, pathology and influence of thymectomy. Ann Surg (1965) 3.00
Successful liver transplantation from crossmatch-positive donors. Transplant Proc (1981) 2.80
Hypoxia inhibits G1/S transition through regulation of p27 expression. J Biol Chem (2000) 2.70
Recombinant Newcastle disease virus as a vaccine vector. J Virol (2001) 2.67
Management of intestinal transplantation in humans. Transplant Proc (1992) 2.62
Improvement of kidney-graft survival with increased numbers of blood transfusions. N Engl J Med (1978) 2.52
Transplantation of kidneys from donors whose hearts have stopped beating. N Engl J Med (1998) 2.48
Association of primary sclerosing cholangitis with HLA-DRw52a. N Engl J Med (1990) 2.40
Isolation of recombinant adeno-associated virus vector-cellular DNA junctions from mouse liver. J Virol (1999) 2.37
Thoracic duct drainage before and after cadaveric kidney transplantation. Surg Gynecol Obstet (1979) 2.33
Heterologous antilymphocyte glubulin, histoincompatiblity matching, and human renal homotransplantation. Surg Gynecol Obstet (1968) 2.23
The relative effects of FK506 and cyclosporine on short- and long-term kidney graft survival. Transplantation (1995) 2.13
Equitable allocation of HLA-compatible kidneys for local pools and minorities. N Engl J Med (1994) 2.12
Reactivity of lymphocytes from normal persons on cultured tumor cells. Cancer Res (1973) 2.11
Survival of nationally shared, HLA-matched kidney transplants from cadaveric donors. The UNOS Scientific Renal Transplant Registry. N Engl J Med (1992) 2.09
Human renal transplants. I. Glomerular changes. Lab Invest (1967) 2.06
Characterization of sialosylated Lewisx as a new tumor-associated antigen. Cancer Res (1984) 2.02
Adeno-associated viral vector-mediated gene transfer of human blood coagulation factor IX into mouse liver. Blood (1998) 1.96
Nomenclature for factors of the HLA system, 2002. Tissue Antigens (2002) 1.89
Analysis of HL-A incompatibility in human renal transplants. Tissue Antigens (1971) 1.89
A semimicro mixed leukocyte culture test. Transplantation (1971) 1.85
The adverse impact on liver transplantation of using positive cytotoxic crossmatch donors. Transplantation (1992) 1.83
Inhibition of FEN-1 processing by DNA secondary structure at trinucleotide repeats. Mol Cell (1999) 1.83
Juvenile myoclonic epilepsy (JME) may be linked to the BF and HLA loci on human chromosome 6. Am J Med Genet (1988) 1.82
Early events in liver allograft rejection. Delineation of sites of simultaneous intragraft and recipient lymphoid tissue sensitization. Am J Pathol (1991) 1.78
Serotyping for homotransplantation. V. Evaluation of a matching scheme. Transplantation (1966) 1.78
Specific interactions between the human RAD51 and RAD52 proteins. J Biol Chem (1996) 1.78
A Ubiquitous Chronic Disease Care system using cellular phones and the internet. Diabet Med (2009) 1.77
Positive crossmatch in primary human liver allografts under cyclosporine or FK 506 therapy. Transplant Proc (1991) 1.77
The DNA repair endonuclease XPG binds to proliferating cell nuclear antigen (PCNA) and shares sequence elements with the PCNA-binding regions of FEN-1 and cyclin-dependent kinase inhibitor p21. J Biol Chem (1997) 1.76
Enhancement of human kidney allografts by cold B-lymphocyte cytotoxins. Lancet (1978) 1.70
Liver transplantation in positive cytotoxic crossmatch cases using FK506, high-dose steroids, and prostaglandin E1. Transplantation (1992) 1.68
Radiation-induced assembly of Rad51 and Rad52 recombination complex requires ATM and c-Abl. J Biol Chem (1999) 1.68
Spinocerebellar ataxia and HLA linkage: risk prediction by HLA typing. N Engl J Med (1977) 1.67
Multiple sclerosis: association with HL-A3. Tissue Antigens (1972) 1.65
Successful renal allografts across a positive cross-match for donor B-lymphocyte alloantigens. Lancet (1976) 1.63
Disturbance of HL-A antigen frequency in Psoriasis. N Engl J Med (1972) 1.63
Cross reactions between human transplantation antigens and bacterial lipopolysaccharides. Transplantation (1973) 1.60
Thoracic duct fistula and renal transplantation. Ann Surg (1979) 1.60
Proliferating cell nuclear antigen facilitates excision in long-patch base excision repair. J Biol Chem (1999) 1.60
Influence of race on kidney transplant survival. Transplant Proc (1977) 1.58
Increased prevalence of W27 in juvenile rheumatoid arthritis. N Engl J Med (1974) 1.58
Brain abnormalities in Sjogren syndrome with recurrent CNS manifestations: association with neuromyelitis optica. Mult Scler (2009) 1.58
Acute respiratory distress syndrome caused by miliary tuberculosis: a multicentre survey in South Korea. Int J Tuberc Lung Dis (2011) 1.58
Treatment of lymphopenic hypogammaglobulinemia and bone-marrow aplasia by transplantation of allogeneic marrow. Crucial role of histocompatiility matching. N Engl J Med (1969) 1.58
Selecting donors of platelets for refractory patients on the basis of HLA antibody specificity. Transfusion (2000) 1.58
Nomenclature for factors of the HLA system, 2004. Tissue Antigens (2005) 1.57
HLA matching and cadaver kidney transplant survival in North America: influence of center variation and presensitization. Transplantation (1977) 1.56
Empirical validation of the Essen-Möller probability of paternity. Am J Hum Genet (1986) 1.56
The TB structural genomics consortium: a resource for Mycobacterium tuberculosis biology. Tuberculosis (Edinb) (2003) 1.55
Follow-up study of juvenile chronic polyarthritis with particular reference to histocompatibility antigen W. 27. Ann Rheum Dis (1974) 1.55
Anti-HLA antibodies after solid organ transplantation. Transplantation (2000) 1.54
Stability of HL-A and appearance of other antigens (LIVA) at the surface of lymphoblasts grown in vitro. Haematologica (1969) 1.53
A combination of HLA-DQ beta Asp57-negative and HLA DQ alpha Arg52 confers susceptibility to insulin-dependent diabetes mellitus. J Clin Invest (1990) 1.51
Impact of IgG3 subclass and C1q-fixing donor-specific HLA alloantibodies on rejection and survival in liver transplantation. Am J Transplant (2015) 1.50
A clinicopathological study of human liver allograft recipients harboring preformed IgG lymphocytotoxic antibodies. Hepatology (1992) 1.50
A novel role in DNA metabolism for the binding of Fen1/Rad27 to PCNA and implications for genetic risk. Mol Cell Biol (1999) 1.49
HL-A antigens and antibody response after influenza A vaccination. Decreased response associated with HL-A type W16. N Engl J Med (1976) 1.49
Frequency dependence of impedances at the acupuncture point Quze (PC3). IEEE Eng Med Biol Mag (2002) 1.46
HLA and the inheritance of multiple sclerosis: linkage analysis of 72 pedigrees. Am J Hum Genet (1980) 1.46
Cytotoxins in disease. 3. Antibodies against lymphocytes produced by vaccination. Transplantation (1970) 1.46
HLA genotypic study of insulin-dependent diabetes the excess of DR3/DR4 heterozygotes allows rejection of the recessive hypothesis. Diabetes (1983) 1.45
Deliberate donor-specific blood transfusions prior to living related renal transplantation. A new approach. Ann Surg (1980) 1.45
Higher risk of kidney graft failure in the presence of anti-angiotensin II type-1 receptor antibodies. Am J Transplant (2013) 1.44
Suppression of lymphocyte transformation by aspirin. Lancet (1973) 1.43
Twins with two different fathers identified by HLA. N Engl J Med (1978) 1.43
Extremely high association between appearance of HLA antibodies and failure of kidney grafts in a five-year longitudinal study. Am J Transplant (2007) 1.43
Paired kidney exchange is not a solution to ABO incompatibility. Transplantation (1998) 1.43
Peritoneal solute clearances in diabetics. Perit Dial Int (1990) 1.42
LIGHT AND ELECTRON MICROSCOPIC STUDY OF BIOPSIES FROM THIRTY-THREE HUMAN RENAL ALLOGRAFTS AND AN ISOGRAFT 134-212 YEARS AFTER TRANSPLANTATION. Ann N Y Acad Sci (1996) 1.42
HL-A W27--a clue to the diagnosis and pathogenesis of Reiter's syndrome. N Engl J Med (1974) 1.41
Meeting the service needs of HIV-infected persons: is the Ryan White CARE Act succeeding? J Acquir Immune Defic Syndr Hum Retrovirol (1997) 1.41
Landsteiner Award. HLA epitope matching. Transfusion (1992) 1.41
Intussusception in adults. Acta Chir Belg (2006) 1.40